Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review



Aghapour SA1 ; Torabizadeh M2 ; Bahreiny SS3 ; Saki N4 ; Jalali Far MA4 ; Yousefiavarvand A5 ; Dost Mohammad Ghasemi K6 ; Aghaei M3, 4 ; Abolhasani MM3 ; Sharifani MS7 ; Sarbazjoda E3 ; Javidan M3
Authors

Source: Iranian Journal of Blood and Cancer Published:2024

Abstract

The dynamic interplay between cellular immunity and tumor cells is essential in cancer advancement and response to therapy. This updated, comprehensive review examines the intricate relationship between these components, focusing on the function of different subsets of immune cells in both innate and acquired immunity. A literature search was conducted to identify cytokines involved in tumor cell induction, using keywords such as cytokines, tumor cells, immune cells, and cancer. Relevant articles published between 2003 and 2024 were reviewed, and their data were summarized. The review highlights the different roles of immune cell subsets in coordinating immune responses against tumors. Tumor-associated macrophages (TAMs) And Myeloid-derived suppressor cells (MDSCs) often stimulate cancer growth and evasion of the immune system by suppressing effector cells. Eosinophils and natural killer (NK) cells contribute to tumor surveillance and cytotoxicity, while dendritic cells (DCs) recreate paramount function in T-cell activation and antigen presentation. The complement system and neutrophils contribute to immune regulation and tumor-associated inflammation. T lymphocytes, particularly antigen-presenting cells (APCs) and cytotoxic CD8+ T cells are central to acquired immunity and the anti-tumor immune response. This review highlights how cytokines interact with tumor cells and their role in cancer biology, paving the way for identifying improved prognostic and diagnostic factors. The compiled findings discuss valuable cytokines for a more effective diagnosis of tumors and an accurate prognosis prediction. © 2024, Iranian Pediatric Hematology and Oncology Society. All rights reserved.
Related Docs
View other Related Docs
1. Prophylactic Dna Vaccine Targeting Foxp3+ Regulatory T Cells Depletes Myeloid-Derived Suppressor Cells and Improves Anti-Melanoma Immune Responses in a Murine Model, Cancer Immunology, Immunotherapy (2018)
2. Immunologic Tumor Microenvironment Modulators for Turning Cold Tumors Hot, Cancer Communications (2024)
3. Immunotherapy a New Hope for Cancer Treatment: A Review, Pakistan Journal of Biological Sciences (2018)
Experts (# of related papers)
View all Related Experts
Nafiseh Esmaeil (3)
Mazdak Ganjalikhani Hakemi (3)
Other Related Docs
4. Regulating the Regulatory T Cells As Cell Therapies in Autoimmunity and Cancer, Frontiers in Medicine (2023)
5. Targeting Immune Checkpoints: How to Use Natural Killer Cells for Fighting Against Solid Tumors, Cancer Communications (2023)
6. Exploring Potential Roles of Long Non-Coding Rnas in Cancer Immunotherapy: A Comprehensive Review, Frontiers in Immunology (2024)
7. Meta-Analytical and Meta-Regression Evaluation of Subclinical Hyperthyroidism's Effect on Male Reproductive Health: Hormonal and Seminal Perspectives, Reproductive Sciences (2024)
8. The Role of Bone Marrow Microenvironment (Bmm) Cells in Acute Myeloid Leukemia (Aml) Progression: Immune Checkpoints, Metabolic Checkpoints, and Signaling Pathways, Cell Communication and Signaling (2023)
9. Immunogenic Cell Death Inducer Peptides: A New Approach for Cancer Therapy, Current Status and Future Perspectives, Biomedicine and Pharmacotherapy (2023)
10. Cancer Vaccine in Cold Tumors: Clinical Landscape, Challenges, and Opportunities, Current Cancer Drug Targets (2022)
11. Genetically Engineered Mesenchymal Stem Cells: Targeted Delivery of Immunomodulatory Agents for Tumor Eradication, Cancer Gene Therapy (2020)
12. Immune-Dysregulation Harnessing in Myeloid Neoplasms, Cancer Medicine (2024)
13. Comparison of Four Methods of Colon Cancer Cell Lysates Preparation for Ex Vivo Maturation of Dendritic Cells, Research in Pharmaceutical Sciences (2022)
14. Tumor-Infiltrating Myeloid Cells; Mechanisms, Functional Significance, and Targeting in Cancer Therapy, Cellular Oncology (2025)
15. Myeloid-Derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-Based Vaccine Function and Improved Immunity in Tumor Mice, Iranian Journal of Allergy, Asthma and Immunology (2018)
16. Immune Checkpoint Inhibition for the Treatment of Cancers: An Update and Critical Review of Ongoing Clinical Trials, Clinical Immunology (2021)
17. Dcs Pulsed With Hypochlorous Acid-Treated Tumor Cell Lysates Present Antigens Efficiently and Induce Cd8 + T Cell Activation Through Cross-Presentation, Research in Pharmaceutical Sciences (2025)
18. The Molecular Perspective on the Melanoma and Genome Engineering of T-Cells in Targeting Therapy, Environmental Research (2023)
19. Pd-L1 Importance in Malignancies Comprehensive Insights Into the Role of Pd-L1 in Malignancies: From Molecular Mechanisms to Therapeutic Opportunities, Clinical and Experimental Medicine (2025)
20. Clinical Combinatorial Treatments Based on Cancer Vaccines: Combination With Checkpoint Inhibitors and Beyond, Current Drug Targets (2022)